PHARMACEUTICAL PRODUCT STEWARDSHIP… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

ANNE VOGEL-MARR

Phone

2024953131

Tax Period

2023-01-01 to 2023-12-31

PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP, founded in 2014, is a community nonprofit in the Community Improvement sector that reported $4.1M in total revenue in fiscal year 2023. Revenue decreased 11% compared to the prior year. Expenses of $3.7M left a modest 8% surplus.

Mission

FACILITATE THE APPROPRIATE AND EFFICIENT DISPOSAL OF UNWANTED HOUSEHOLD MEDICINES AND HOME GENERATED SHARPS BY PROVIDING INFRASTRUCTURE, GUIDANCE, AND SUBJECT MATTER EXPERTISE TO SUPPORT MEMBER COMPLIANCE AND IMPROVE AWARENESS OF EXISTING PHARMACEUTICAL DISPOSAL OPTIONS.

Program Service Accomplishments

Program 1

COMMUNICATION AND PROGRAM ADMINISTRATION: PPSWG PROVIDES A FORUM TO DEVELOP CONSENSUS AMONG PHARMACEUTICAL AND SHARPS MANUFACTURERS AND A FRAMEWORK FOR ADDRESSING COMPLIANCE WITH HOUSEHOLD-GENERATED UNWANTED PHARMACEUTICAL AND SHARPS PRODUCTS STEWARDSHIP LEGISLATION THROUGH ACTIVE MEMBER ENGAGEMENT. PPSWG RAISES PUBLIC AWARENESS ABOUT THE APPROPRIATE DISPOSAL METHODS FOR HOUSEHOLD-GENERATED UNWANTED PHARMACEUTICAL AND SHARPS PRODUCTS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $3,955,177

Investment Income $100,242

Other Revenue $14,600

TOTAL REVENUE $4,070,019

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $3,741,383

TOTAL EXPENSES $3,741,383

Year-over-Year Comparison

	2023	2022	Change
Revenue	$4,070,019	$4,574,979	-0.1%
Expenses	$3,741,383	$3,991,401	-0.1%
Net Income	$328,636	$583,578	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
COLIN CHILES	CHAIR	0.40	Officer Director	$0	$0	$0
ANNE MURRAY	PAST CHAIR	0.40	Officer Director	$0	$0	$0
BARBARA MORROW	VICE CHAIR	0.40	Officer Director	$0	$0	$0
SHAWN BROWN	SECRETARY/TREASURER	0.40	Officer Director	$0	$0	$0
BEENA PATEL	DIRECTOR	0.40	Director	$0	$0	$0
STEVE GIULI	DIRECTOR	0.40	Director	$0	$0	$0
KATE KULESHER	DIRECTOR	0.40	Director	$0	$0	$0
DREW REAVIS	DIRECTOR	0.40	Director	$0	$0	$0
TRAVIS SHAW	DIRECTOR	0.40	Director	$0	$0	$0
ANNE VOGEL-MARR	EXECUTIVE DIRECTOR	40.00	Officer	$0	$0	$0
MELISSA LETENDRE	VICE PRESIDENT, FINANCE	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$4,070,019	$3,741,383	$22,293,395	$328,636
2022	$4,574,979	$3,991,401	$23,702,827	$583,578
2021	$4,237,748	$3,775,155	$5,361,377	$462,593
2020	$4,177,629	$3,500,049	$23,156,046	$677,580
2019	$44,283,369	$26,350,085	$48,181,165	$17,933,284
2018	$17,160,642	$15,849,343	$13,155,547	$1,311,299

PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP